Work

A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer

Year: 2021

Type: article

Study design: Clinical Trial

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2021.08.003

Authors: Patricia LoRusso, Erika Hamilton, Cynthia Ma, Neelima Vidula, Rebecca G. Bagley, Steven Troy, Miriam Annett, Ziyang Yu, Maureen G. Conlan, Amy Weise

Institutions: Yale Cancer Center, Sarah Cannon, Tennessee Oncology, Washington University in St. Louis, Massachusetts General Hospital, Radius Health (United States), The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Radius Health

OpenAlex ID: W3194889667

FWCI: 1.838

Cites: 36

Cited by: 24

Related to: 10